Call for tender

On 11/10/2017 the prior information notice for the project Anti-SUPERBugs has been published in the European Tenders Electronic Daily. The Anti-SUPERBugs pre-commercial procurement aims to improve the quality of care processes in hospital and the reduction of both the costs and the collateral effects provoked by Multi-Drug Resistant Organisms (MDROs, otherwise known as Superbugs) and other Health Associated Infections (HAIs) pathogens, through the development and testing of prototypes of devices and ICT services that can:

  1. test non-invasively for the presence of MDROs and other pathogens, and
  2. provide continuous information and remote alerts to health professionals on environmental contamination by MDROs — and other pathogens — on high contact surfaces, applicable to existing healthcare environments.

More details are available here. The Challenge Brief in a Nutshell

 

The Request for Tender was published on July 26th 2019 and the four bidders awarded with Phase 1 contracts were:

  • Culture (composed by the entities: Bahia Software, SLU (ES), Fundación Centro Tecnolóxico de Telecomunicaciones de Galicia (Gradiant ES), International Iberian Nanotechnology Laboratory(INL));
  • Sens4Care (composed by the entities Tech4care S.R.L (IT) – Sens Solutions(ES));
  • ABS-IMS2 (composed by the entities ION-GAS GmbH (DE), Meta IT GmbH (DE), Logic Way GmbH (DE), Unabhängiges Centrum für empirische Markt- und Sozialforschung GmbH (DE));
  • Bugwatcher (composed by the entities: PULSO EDICIONES SL (ES), NuWave Sensor Technology Ltd (IE), PaperDrop Diagnostics SL (ES)).

More info available here.

The Invitation to join Phase 2 Prototyping was issued on June 3rd 2020 and the three bidders awarded with Phase 2 contracts were:

  • Culture (composed by the entities: Bahia Software, SLU (ES), Fundación Centro Tecnolóxico de Telecomunicaciones de Galicia (Gradiant ES), International Iberian Nanotechnology Laboratory(INL));
  • Sens4Care (composed by the entities Tech4care S.R.L (IT) – Sens Solutions(ES));
  • Bugwatcher (composed by the entities: PULSO EDICIONES SL (ES), NuWave Sensor Technology Ltd (IE), PaperDrop Diagnostics SL (ES)).

More info available here.

The Invitation to join Phase 3 Proof of concept and solution test in clinical setting was issued on May 11th  2021 and the two bidders awarded with Phase 3 contracts were:

  • Sens4Care (composed by the entities Tech4care S.R.L (IT) – Sens Solutions(ES));
  • Bugwatcher (composed by the entities: PULSO EDICIONES SL (ES), NuWave Sensor Technology Ltd (IE), PaperDrop Diagnostics SL (ES)).

More info available here.